Landscape Capital Management’s Biotech Acquisition Company Unit BIOTU Stock Holding History

Landscape Capital Management’s Portfolio BIOTU Stock Details BIOTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-22,034	Closed	-$218K	–	1080
2022 Q1	$218K	Hold	22,034	–	–	0.03%	557
2021 Q4	$223K	Hold	22,034	–	–	0.03%	467
2021 Q3	$221K	Hold	22,034	–	–	0.03%	459
2021 Q2	$222K	Buy	22,034 +9,618	+77%	+$96.4K	0.03%	420
2021 Q1	$123K	Buy	+12,416	New	+$128K	0.02%	380

Other funds holding BIOTU

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Landscape Capital Management's BIOTU Position: Q2 2022 in Review

Landscape Capital Management sold out of Biotech Acquisition Company Unit (BIOTU) in Q2 2022, closing a stake of 22,034 shares — an estimated $218K sold.

Landscape Capital Management first reported a position in BIOTU in Q1 2021 and held it in 5 quarters. The position peaked at $223K in Q4 2021. 5 funds tracked by Wall St. Rank hold BIOTU as of Q2 2022.

Landscape Capital Management reported no remaining Biotech Acquisition Company Unit position as of Q2 2022 after selling out during the quarter.
Landscape Capital Management sold 22,034 Biotech Acquisition Company Unit shares in Q2 2022, an estimated $218K.
Landscape Capital Management first reported a position in Biotech Acquisition Company Unit in Q1 2021 and held it in 5 quarters.
Landscape Capital Management's Biotech Acquisition Company Unit position peaked at $223K in Q4 2021.
5 funds tracked by Wall St. Rank held Biotech Acquisition Company Unit as of Q2 2022.

Based on Landscape Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.